Zachariah Reitano, co-founder and CEO of telehealth company Ro, highlighted the increasing advantages of remaining a private entity during an Axios event. Although he refrained from confirming any immediate IPO plans, Reitano expressed a commitment to enhancing patient services. Ro has secured over $1 billion in venture funding, with its latest round valuing the company at $6.6 billion. The firm is also expanding its offerings in weight loss drugs, which are rapidly gaining popularity. This strategy reflects a broader trend among late-stage startups opting for privacy over public listings.